AU2023286941A1 — Benzoheterocyclic substituted tetrahydroisoquinoline compound salt form and preparation method therefor
Assigned to Shanghai Jeyou Pharmaceutical Co Ltd · Expires 2025-01-16 · 1y expired
What this patent protects
Disclosed are a benzoheterocyclic substituted tetrahydroisoquinoline compound salt form and a preparation method therefor. Specifically, disclosed are an amorphous form and salt form of the compound as shown in formula (I), and a use thereof to inhibit NHE-mediated sodium ion or …
USPTO Abstract
Disclosed are a benzoheterocyclic substituted tetrahydroisoquinoline compound salt form and a preparation method therefor. Specifically, disclosed are an amorphous form and salt form of the compound as shown in formula (I), and a use thereof to inhibit NHE-mediated sodium ion or hydrogen ion reverse transfer.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.